Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

Prognostic value of neoadjuvant treatment response in locally advanced esophageal adenocarcinoma.

Groth SS, Burt BM, Farjah F, Smaglo BG, Sada YH, Sugarbaker DJ, Massarweh NN.

J Thorac Cardiovasc Surg. 2018 Dec 15. pii: S0022-5223(18)33307-5. doi: 10.1016/j.jtcvs.2018.11.131. [Epub ahead of print]

PMID:
30711279
2.

The elusive ground glass opacity, revealed.

Korb ML, Burt BM.

J Thorac Dis. 2018 Nov;10(Suppl 33):S3828-S3830. doi: 10.21037/jtd.2018.09.41. No abstract available.

3.

Stage the Mediastinum.

Burt BM.

J Thorac Cardiovasc Surg. 2018 Nov 24. pii: S0022-5223(18)33140-4. doi: 10.1016/j.jtcvs.2018.11.037. [Epub ahead of print] No abstract available.

PMID:
30579540
4.

A thinner peel to peel: Pleural thickness is prognostic in mesothelioma.

Groth SS, Ripley RT, Burt BM.

J Thorac Cardiovasc Surg. 2019 Jan;157(1):414-415. doi: 10.1016/j.jtcvs.2018.10.005. Epub 2018 Oct 12. No abstract available.

PMID:
30557957
5.

To slay a dragon: Timing of chemotherapy in resectable pleural mesothelioma.

Burt BM, Ripley RT, Groth SS.

J Thorac Cardiovasc Surg. 2019 Feb;157(2):767-768. doi: 10.1016/j.jtcvs.2018.10.110. Epub 2018 Nov 2. No abstract available.

PMID:
30527720
6.

Approach to a Posterior Cervico-mediastinal Ganglioneuroma.

Lee F, Yu W, Loor G, Burt BM.

Ann Thorac Surg. 2018 Oct 23. pii: S0003-4975(18)31519-4. doi: 10.1016/j.athoracsur.2018.08.092. [Epub ahead of print]

PMID:
30365962
7.

Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation.

Tsao AS, Lindwasser OW, Adjei AA, Adusumilli PS, Beyers ML, Blumenthal GM, Bueno R, Burt BM, Carbone M, Dahlberg SE, de Perrot M, Fennell DA, Friedberg J, Gill RR, Gomez DR, Harpole DH Jr, Hassan R, Hesdorffer M, Hirsch FR, Hmeljak J, Kindler HL, Korn EL, Liu G, Mansfield AS, Nowak AK, Pass HI, Peikert T, Rimner A, Robinson BWS, Rosenzweig KE, Rusch VW, Salgia R, Sepesi B, Simone CB 2nd, Sridhara R, Szlosarek P, Taioli E, Tsao MS, Yang H, Zauderer MG, Malik SM.

J Thorac Oncol. 2018 Nov;13(11):1655-1667. doi: 10.1016/j.jtho.2018.08.2036. Epub 2018 Sep 25.

PMID:
30266660
8.

Povidone-iodine results in rapid killing of thymic epithelial tumour cells through cellular fixation.

Lee HS, Jang HJ, Lo EM, Truong CY, Groth SS, Friedberg JS, Sugarbaker DJ, Burt BM.

Interact Cardiovasc Thorac Surg. 2018 Aug 27. doi: 10.1093/icvts/ivy248. [Epub ahead of print]

PMID:
30165653
9.

Standardizing the time-honored wedge resection.

Hamaji M, Miyahara S, Lee HS, Burt BM.

J Thorac Dis. 2018 Jul;10(Suppl 18):S2206-S2208. doi: 10.21037/jtd.2018.06.155. No abstract available.

10.

Mutation Ensemble for Response to Programmed Cell Death 1 Inhibition in Thymic Carcinoma.

Lee HS, Truong CY, Burt BM.

J Thorac Oncol. 2018 Aug;13(8):e150-e152. doi: 10.1016/j.jtho.2018.03.027. No abstract available.

PMID:
30049379
11.

A Phase I Trial of Surgical Resection and Intraoperative Hyperthermic Cisplatin and Gemcitabine for Pleural Mesothelioma.

Burt BM, Richards WG, Lee HS, Bartel S, Dasilva MC, Gill RR, Jaklitsch MT, Johnson BE, Swanson SJ, Bueno R, Sugarbaker DJ.

J Thorac Oncol. 2018 Sep;13(9):1400-1409. doi: 10.1016/j.jtho.2018.04.032. Epub 2018 May 9.

PMID:
29753120
12.

Guidelines for stereotactic body radiation therapy treatment of lung cancer highlight important research questions: what is the next step?

Cornwell LD, Korb ML, Burt BM.

J Thorac Dis. 2018 Mar;10(3):1339-1342. doi: 10.21037/jtd.2018.03.36. No abstract available.

13.

Giant Mediastinal Liposarcoma: A Rare Yet Distinct Clinical Entity.

Nguyen DC, Olatubosun O, Yu W, Loor G, Burt BM.

Ann Thorac Surg. 2018 Sep;106(3):e117-e119. doi: 10.1016/j.athoracsur.2018.03.018. Epub 2018 Apr 12.

PMID:
29654722
14.

IL17A Regulates Tumor Latency and Metastasis in Lung Adeno and Squamous SQ.2b and AD.1 Cancer.

You R, DeMayo FJ, Liu J, Cho SN, Burt BM, Creighton CJ, Casal RF, Lazarus DR, Lu W, Tung HY, Yuan X, Hill-McAlester A, Kim M, Perusich S, Cornwell L, Rosen D, Song LZ, Paust S, Diehl G, Corry D, Kheradmand F.

Cancer Immunol Res. 2018 Jun;6(6):645-657. doi: 10.1158/2326-6066.CIR-17-0554. Epub 2018 Apr 13.

15.

Thoracic outlet syndrome for thoracic surgeons.

Burt BM.

J Thorac Cardiovasc Surg. 2018 Sep;156(3):1318-1323.e1. doi: 10.1016/j.jtcvs.2018.02.096. Epub 2018 Mar 13. No abstract available.

PMID:
29628349
16.

Comprehensive immunoproteogenomic analyses of malignant pleural mesothelioma.

Lee HS, Jang HJ, Choi JM, Zhang J, de Rosen VL, Wheeler TM, Lee JS, Tu T, Jindra PT, Kerman RH, Jung SY, Kheradmand F, Sugarbaker DJ, Burt BM.

JCI Insight. 2018 Apr 5;3(7). pii: 98575. doi: 10.1172/jci.insight.98575. [Epub ahead of print]

17.

Therapeutic R2 resection for pleural mesothelioma.

Nguyen D, Sugarbaker DJ, Burt BM.

J Thorac Cardiovasc Surg. 2018 Jun;155(6):2734-2735. doi: 10.1016/j.jtcvs.2018.01.025. Epub 2018 Feb 1. No abstract available.

PMID:
29477257
18.

The printed trachea.

Patel V, Burt BM.

J Thorac Dis. 2017 Oct;9(10):3672-3673. doi: 10.21037/jtd.2017.09.49. No abstract available.

19.

The importance of R0.

Ibrahim K, Burt BM.

J Thorac Cardiovasc Surg. 2018 Jan;155(1):428-429. doi: 10.1016/j.jtcvs.2017.09.064. No abstract available.

PMID:
29245203
20.

Computed Tomography Features associated With the Eighth Edition TNM Stage Classification for Thymic Epithelial Tumors.

Padda SK, Terrone D, Tian L, Khuong A, Neal JW, Riess JW, Berry MF, Hoang CD, Burt BM, Leung AN, Schwartz EJ, Shrager JB, Wakelee HA.

J Thorac Imaging. 2018 May;33(3):176-183. doi: 10.1097/RTI.0000000000000310.

PMID:
29219888
21.

Paraneoplastic Syndromes and Thymic Malignancies: An Examination of the International Thymic Malignancy Interest Group Retrospective Database.

Padda SK, Yao X, Antonicelli A, Riess JW, Shang Y, Shrager JB, Korst R, Detterbeck F, Huang J, Burt BM, Wakelee HA, Badve SS.

J Thorac Oncol. 2018 Mar;13(3):436-446. doi: 10.1016/j.jtho.2017.11.118. Epub 2017 Nov 27.

PMID:
29191778
22.

Programmed death ligand 1-associated antitumor immunity in early-stage non-small cell lung cancer: Expression of major histocompatibility complex I as a prerequisite.

Burt BM.

J Thorac Cardiovasc Surg. 2018 Jan;155(1):393-394. doi: 10.1016/j.jtcvs.2017.08.061. Epub 2017 Sep 1. No abstract available.

PMID:
28967424
23.

Soluble Mesothelin-Related Peptides to Monitor Recurrence After Resection of Pleural Mesothelioma.

Burt BM, Lee HS, Lenge De Rosen V, Hamaji M, Groth SS, Wheeler TM, Sugarbaker DJ.

Ann Thorac Surg. 2017 Nov;104(5):1679-1687. doi: 10.1016/j.athoracsur.2017.06.042. Epub 2017 Sep 28.

PMID:
28964420
24.

Subspecialty certification in thoracic oncology: Toward your next diploma.

Groth SS, Burt BM.

J Thorac Cardiovasc Surg. 2017 Oct;154(4):1393-1394. doi: 10.1016/j.jtcvs.2017.08.001. Epub 2017 Aug 12. No abstract available.

PMID:
28918926
25.

Extending the survival advantage of ground glass.

Lee F, Burt BM.

J Thorac Dis. 2017 Jul;9(7):1828-1830. doi: 10.21037/jtd.2017.06.83. No abstract available.

26.

Cancer Immunotherapy: Historical Perspective of a Clinical Revolution and Emerging Preclinical Animal Models.

Decker WK, da Silva RF, Sanabria MH, Angelo LS, GuimarĂ£es F, Burt BM, Kheradmand F, Paust S.

Front Immunol. 2017 Aug 2;8:829. doi: 10.3389/fimmu.2017.00829. eCollection 2017. Review.

27.

Intraoperative adjuncts for malignant pleural mesothelioma.

Chan WH, Sugarbaker DJ, Burt BM.

Transl Lung Cancer Res. 2017 Jun;6(3):285-294. doi: 10.21037/tlcr.2017.05.04. Review.

28.

Overall Survival Following Thoracoscopic vs Open Lobectomy for Early-stage Non-small Cell Lung Cancer: A Meta-analysis.

Hamaji M, Lee HS, Kawaguchi A, Burt BM.

Semin Thorac Cardiovasc Surg. 2017 Spring;29(1):104-112. doi: 10.1053/j.semtcvs.2017.01.009. Epub 2017 Feb 22. Review.

PMID:
28683985
29.

Incompletely resected non-small cell lung cancer: Do we know how to handle a positive margin?

Burt BM.

J Thorac Cardiovasc Surg. 2017 Aug;154(2):673-674. doi: 10.1016/j.jtcvs.2017.04.009. Epub 2017 Apr 12. No abstract available.

PMID:
28526498
30.

Alternative conduits for esophageal replacement.

Bakshi A, Sugarbaker DJ, Burt BM.

Ann Cardiothorac Surg. 2017 Mar;6(2):137-143. doi: 10.21037/acs.2017.03.07.

31.

Genomic Analysis of Thymic Epithelial Tumors Identifies Novel Subtypes Associated with Distinct Clinical Features.

Lee HS, Jang HJ, Shah R, Yoon D, Hamaji M, Wald O, Lee JS, Sugarbaker DJ, Burt BM.

Clin Cancer Res. 2017 Aug 15;23(16):4855-4864. doi: 10.1158/1078-0432.CCR-17-0066. Epub 2017 Apr 11.

32.

A Meta-Analysis of Postoperative Radiotherapy for Thymic Carcinoma.

Hamaji M, Shah RM, Ali SO, Bettenhausen A, Lee HS, Burt BM.

Ann Thorac Surg. 2017 May;103(5):1668-1675. doi: 10.1016/j.athoracsur.2016.12.042. Epub 2017 Mar 31. Review.

PMID:
28366466
33.

Clarity and clairvoyance: Review and prediction of management guidelines for early stage lung cancer.

Burt BM.

J Thorac Cardiovasc Surg. 2017 Jun;153(6):1563-1564. doi: 10.1016/j.jtcvs.2017.01.040. Epub 2017 Feb 8. No abstract available.

PMID:
28268008
34.

Thoracoscopic lobectomy for clinical N2 and N1 lung cancer: Innovation outpacing standard of care.

Burt BM.

J Thorac Cardiovasc Surg. 2017 Apr;153(4):977-978. doi: 10.1016/j.jtcvs.2016.12.022. Epub 2017 Jan 10. No abstract available.

PMID:
28168981
35.

Radiography nomography: Utility of a calculator in rational preoperative decision making for subsolid pulmonary nodules.

Burt BM.

J Thorac Cardiovasc Surg. 2017 Feb;153(2):460-461. doi: 10.1016/j.jtcvs.2016.10.047. Epub 2016 Nov 3. No abstract available.

36.

Akt and SHP-1 are DC-intrinsic checkpoints for tumor immunity.

Carmi Y, Prestwood TR, Spitzer MH, Linde IL, Chabon J, Reticker-Flynn NE, Bhattacharya N, Zhang H, Zhang X, Basto PA, Burt BM, Alonso MN, Engleman EG.

JCI Insight. 2016 Nov 3;1(18):e89020.

37.

Determinants of Complete Resection of Thymoma by Minimally Invasive and Open Thymectomy: Analysis of an International Registry.

Burt BM, Yao X, Shrager J, Antonicelli A, Padda S, Reiss J, Wakelee H, Su S, Huang J, Scott W.

J Thorac Oncol. 2017 Jan;12(1):129-136. doi: 10.1016/j.jtho.2016.08.131. Epub 2016 Aug 24.

38.

Integrated genomic analysis of recurrence-associated small non-coding RNAs in oesophageal cancer.

Jang HJ, Lee HS, Burt BM, Lee GK, Yoon KA, Park YY, Sohn BH, Kim SB, Kim MS, Lee JM, Joo J, Kim SC, Yun JS, Na KJ, Choi YL, Park JL, Kim SY, Lee YS, Han L, Liang H, Mak D, Burks JK, Zo JI, Sugarbaker DJ, Shim YM, Lee JS.

Gut. 2017 Feb;66(2):215-225. doi: 10.1136/gutjnl-2015-311238. Epub 2016 Aug 9.

39.

Utility of Adjuvant Chemotherapy After Neoadjuvant Chemoradiation and Esophagectomy for Esophageal Cancer.

Burt BM, Groth SS, Sada YH, Farjah F, Cornwell L, Sugarbaker DJ, Massarweh NN.

Ann Surg. 2017 Aug;266(2):297-304. doi: 10.1097/SLA.0000000000001954.

PMID:
27501170
40.

Progression of EGFR-Mutant Lung Adenocarcinoma is Driven By Alveolar Macrophages.

Wang DH, Lee HS, Yoon D, Berry G, Wheeler TM, Sugarbaker DJ, Kheradmand F, Engleman E, Burt BM.

Clin Cancer Res. 2017 Feb 1;23(3):778-788. doi: 10.1158/1078-0432.CCR-15-2597. Epub 2016 Aug 5.

41.

Role of thoracoscopy, mediastinoscopy and laparoscopy in the diagnosis and staging of malignant pleural mesothelioma.

Wald O, Groth SS, Burt BM, Sugarbaker DJ.

J Vis Surg. 2016 Aug 2;2:129. doi: 10.21037/jovs.2016.07.12. eCollection 2016. Review.

42.

The ascent of POEM: Double-tunnel per oral endoscopic re-myotomy.

Burt BM.

J Thorac Cardiovasc Surg. 2016 Jun;151(6):e103-4. doi: 10.1016/j.jtcvs.2016.02.010. Epub 2016 Feb 12. No abstract available.

43.

Basic experiments of bioabsorbable materials in prevention of postoperative intrapleural adhesions following thoracotomy.

Hamaji M, Burt BM, Date H, Nakamura T.

Gen Thorac Cardiovasc Surg. 2016 Feb;64(2):82-6. doi: 10.1007/s11748-015-0612-1. Epub 2015 Dec 10. Review.

PMID:
26662634
44.

Invited Commentary.

Burt BM.

Ann Thorac Surg. 2015 Nov;100(5):1874. doi: 10.1016/j.athoracsur.2015.04.090. No abstract available.

PMID:
26522527
45.

The Prevention and Management of Air Leaks Following Pulmonary Resection.

Burt BM, Shrager JB.

Thorac Surg Clin. 2015 Nov;25(4):411-9. doi: 10.1016/j.thorsurg.2015.07.002. Epub 2015 Sep 8. Review.

PMID:
26515941
46.

Influence of experience and the surgical learning curve on long-term patient outcomes in cardiac surgery.

Burt BM, ElBardissi AW, Huckman RS, Cohn LH, Cevasco MW, Rawn JD, Aranki SF, Byrne JG.

J Thorac Cardiovasc Surg. 2015 Nov;150(5):1061-7, 1068.e1-3. doi: 10.1016/j.jtcvs.2015.07.068. Epub 2015 Aug 1.

47.

Surgery versus SABR for resectable non-small-cell lung cancer.

Hamaji M, Groth SS, Sugarbaker DJ, Burt BM.

Lancet Oncol. 2015 Aug;16(8):e372. doi: 10.1016/S1470-2045(15)00091-1. No abstract available.

PMID:
26248839
48.

Diameter of Solid Tumor Component Alone Should be Used to Establish T Stage in Lung Adenocarcinoma.

Burt BM, Leung AN, Yanagawa M, Chen W, Groth SS, Hoang CD, Nair VS, Shrager JB.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1318-23. doi: 10.1245/s10434-015-4780-0. Epub 2015 Jul 31.

PMID:
26228108
49.

Management of Complications After Pneumonectomy.

Groth SS, Burt BM, Sugarbaker DJ.

Thorac Surg Clin. 2015 Aug;25(3):335-48. doi: 10.1016/j.thorsurg.2015.04.006. Epub 2015 Jun 12. Review.

PMID:
26210929
50.

Pleurectomy and decortication for metastatic renal cell carcinoma.

Bettenhausen A, Hamaji M, Burt BM, Ali SO.

J Thorac Cardiovasc Surg. 2015 Jul;150(1):e3-5. doi: 10.1016/j.jtcvs.2015.05.007. Epub 2015 May 7. No abstract available.

Supplemental Content

Support Center